162 related articles for article (PubMed ID: 15148529)
1. The role of botulinum toxin in neurourology.
Schurch B
Drugs Today (Barc); 2004 Mar; 40(3):205-12. PubMed ID: 15148529
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin as a new therapy option for voiding disorders: current state of the art.
Leippold T; Reitz A; Schurch B
Eur Urol; 2003 Aug; 44(2):165-74. PubMed ID: 12875934
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological treatment of neurogenic detrusor hyperactivity: intradetrusor botulinum toxin A injections].
Karsenty G; Corcos J; Schurch B; Ruffion A; Chartier-Kastler E
Prog Urol; 2007 May; 17(3):568-75. PubMed ID: 17622092
[TBL] [Abstract][Full Text] [Related]
4. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
Prescrire Int; 2013 Jan; 22(134):12-3. PubMed ID: 23367677
[TBL] [Abstract][Full Text] [Related]
6. [Botulinum toxin in urology. Indications and results].
Schurch B; Reitz A
Urologe A; 2004 Nov; 43(11):1410-5. PubMed ID: 15309305
[TBL] [Abstract][Full Text] [Related]
7. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.
Reitz A; Stöhrer M; Kramer G; Del Popolo G; Chartier-Kastler E; Pannek J; Burgdörfer H; Göcking K; Madersbacher H; Schumacher S; Richter R; von Tobel J; Schurch B
Eur Urol; 2004 Apr; 45(4):510-5. PubMed ID: 15041117
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic outcome and quality of life between urethral and detrusor botulinum toxin treatment for patients with spinal cord lesions and detrusor sphincter dyssynergia.
Kuo HC
Int J Clin Pract; 2013 Oct; 67(10):1044-9. PubMed ID: 24073977
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity.
Alvares RA; Silva JA; Barboza AL; Monteiro RT
Int Braz J Urol; 2010; 36(6):732-7. PubMed ID: 21176280
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Utomo E; Groen J; Blok BF
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin injections for paediatric incontinence.
Schurch B; Corcos J
Curr Opin Urol; 2005 Jul; 15(4):264-7. PubMed ID: 15928517
[TBL] [Abstract][Full Text] [Related]
12. Injection of botulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: a review of indications, techniques and results.
Karsenty G; Baazeem A; Elzayat E; Corcos J
Can J Urol; 2006 Apr; 13(2):3027-33. PubMed ID: 16672114
[TBL] [Abstract][Full Text] [Related]
13. Urologic applications of botox.
Moore C; Rackley R; Goldman H
Curr Urol Rep; 2005 Nov; 6(6):419-23. PubMed ID: 16238914
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions.
Klaphajone J; Kitisomprayoonkul W; Sriplakit S
Arch Phys Med Rehabil; 2005 Nov; 86(11):2114-8. PubMed ID: 16271557
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia.
Chen CY; Liao CH; Kuo HC
Spinal Cord; 2011 May; 49(5):659-64. PubMed ID: 21243000
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
[TBL] [Abstract][Full Text] [Related]
17. Current and potential urological applications of botulinum toxin A.
Jiang YH; Liao CH; Kuo HC
Nat Rev Urol; 2015 Sep; 12(9):519-33. PubMed ID: 26260879
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for the management of bladder dysfunction.
Schurch B
Drugs; 2006; 66(10):1301-18. PubMed ID: 16903766
[TBL] [Abstract][Full Text] [Related]
19. Comparing a transrectal ultrasound-guided with a cystoscopy-guided botulinum toxin a injection in treating detrusor external sphincter dyssynergia in spinal cord injury.
Chen SL; Bih LI; Chen GD; Huang YH; You YH
Am J Phys Med Rehabil; 2011 Sep; 90(9):723-30. PubMed ID: 21552106
[TBL] [Abstract][Full Text] [Related]
20. [Botulinum toxin in urology. An inventory].
Schulte-Baukloh H; Knispel HH
Urologe A; 2004 Aug; 43(8):963-75. PubMed ID: 15278202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
